PT34 Assessment of Direct, Indirect, and Intangible Costs of Rheumatoid Arthritis in Patients Receiving Biological Therapy in Morocco: Ecoram Study
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.2447
https://www.valueinhealthjournal.com/article/S1098-3015(24)02661-5/fulltext
Title :
PT34 Assessment of Direct, Indirect, and Intangible Costs of Rheumatoid Arthritis in Patients Receiving Biological Therapy in Morocco: Ecoram Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)02661-5&doi=10.1016/j.jval.2024.03.2447
First page :
Section Title :
Open access? :
No
Section Order :
11288